Patent intelligence · US
US 12005126
Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption
Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption
Patent details — US 12005126
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 11, 2024
- Expiration
- Jun 6, 2044
- Applicant
- ALMIRA PHARMA SRL
- Claims
- 3
- CPC classes
- A61K, A61K31/722, A61K31/737, A61K47/61
Quick answer
US 12005126 (Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption) is held by ALMIRA PHARMA SRL. Status: granted. Granted Jun 11, 2024. Expires Jun 6, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALMIRA PHARMA SRL
- Grant date
- Expiration
- Claims
- 3
- CPC classes
- A61K, A61K31/722, A61K31/737, A61K47/61, A61K47/6939, A61K47/6943
More from ALMIRA PHARMA SRL
Related pharmaceutical patents in our USPTO index.
-
US 12421228
Naphthyridine derivatives as PRC2 inhibitors
granted -
US 12421253
Tetrahydropyridopyrimidine pan-KRas inhibitors
granted -
US 12414911
Topical compositions and methods of use
granted -
US 12412764
Substrate-accommodating container
granted -
US 12398154
Azaquinazoline pan-KRas inhibitors
granted -
US 12383503
Adagrasib solid pharmaceutical compositions
granted -
US 12377101
Combination therapies
granted -
US 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted
Frequently asked questions
What is US patent 12005126?
US 12005126 (Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption) is held by ALMIRA PHARMA SRL. Status: granted. Granted Jun 11, 2024. Expires Jun 6, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12005126?
ALMIRA PHARMA SRL is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 308 pharmaceutical patents for this assignee.
When does US 12005126 expire?
Our index shows an expiration date of Jun 6, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.